7.4.1 Drugs for urinary retention
Alfuzosin
Alfuzosin 10mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Alfuzosin 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Doxazosin
Doxazosin 1mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Doxazosin 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Doxazosin 4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Dutasteride
Dutasteride 500microgram capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Finasteride
Finasteride 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Tamsulosin
Tamsulosin 400microgram modified-release capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |
Tamsulosin + Dutasteride
Tamsulosin 400microgram / Dutasteride 500microgram capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Benign prostatic hyperplasia |